View Image
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers – topic of research paper in Biological sciences. Download scholarly article PDF and read
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Physiology of serum free light chains - Renal Fellow Network
Serum Free Light Chains and the Risk of ESRD and Death in CKD Article
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers | BMC Nephrology | Full Text
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Correspondence data for kappa and lambda free light chain analysis | Download Table
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
Kappa free light chain reduction ratio per patient and treatment protocol. | Download Table
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
